⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899789 | 0.73 | — | — | |
| SCHEMBL9402147 | 0.73 | — | — | |
| SCHEMBL4450142 | 0.71 | — | — | |
| SCHEMBL28168136 | 0.69 | CYP2D6 (1.00) | — | |
| SCHEMBL213024 | 0.69 | CYP2D6 (1.00) | — | |
| SCHEMBL3134391 | 0.69 | CYP2D6 (1.00) | — | |
| SCHEMBL1663683 | 0.69 | — | — | |
| SCHEMBL1573678 | 0.69 | — | — | |
| SCHEMBL190067 | 0.69 | CYP2D6 (1.00) | — | |
| Formamide SCHEMBL27919767 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023225661-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-23 | — | — | WO | claimed |
| EP-2506858-B1 | MIXTURES OF STARCH DERIVATIVES | BRAUN MELSUNGEN AG (DE) | 2017-05-10 | — | — | EP | claimed |
| EP-1543019-A2 | MODIFIED PNA MOLECULES | Santaris Pharma A/S (DK) | 2005-06-22 | — | — | EP | claimed |
| WO-2004024757-A2 | MODIFIED PNA MOLECULES | SANTARIS PHARMA A/S (DK) | 2004-03-25 | — | — | WO | claimed |
| WO-2002053574-A2 | MODIFIED PNA MOLECULES | PANTHECO A/S (DK) | 2002-07-11 | — | — | WO | claimed |
| WO-2024120466-A1 | MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO., LTD (CN) | 2024-06-13 | — | — | WO | disclosed |
| CN-111351781-B | Electrochemiluminescence analysis device and method for analyzing sample using the same | 麦德龙生物株式会社 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023225661-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-111351781-A | Electrochemiluminescence analysis apparatus and method of analyzing sample using the same | 麦德龙生物株式会社 | 2020-06-30 | — | — | CN | disclosed |
| CN-105209016-A | Biocompatible hydrogel polymer matrices for cell delivery | MEDICUS BIOSCIENCES LLC | 2015-12-30 | — | — | CN | disclosed |
| CN-103917561-A | Pulmonary hypertension | UNIV SHEFFIELD | 2014-07-09 | — | — | CN | disclosed |
| CN-101687909-B | Composition for preventing or treating lung disease | NISSHIN PHARMA INC | 2013-12-18 | — | — | CN | disclosed |
| US-4719288-A | HYPOTENSIVE | CIBA-GEIGY CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0231124-A2 | Cephalosporin derivatives, salts thereof, process for their manufacture, and pharmaceutical agents comprising them | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1987-08-05 | — | — | EP | disclosed |
| US-4613676-A | PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-23 | — | — | US | disclosed |
| EP-0143746-A2 | 5-Amino 4-hydroxy-valeryl-substituted derivatives | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | disclosed |
| US-4506088-A | SULFONYL CONTAINING | STAUFFER CHEMICAL COMPANY (US) | 1985-03-19 | — | — | US | disclosed |
| US-4400203-A | FOR CARBAMATE HERBICIDES | STAUFFER CHEMICAL COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
| US-4308269-A | ANTITUMOUR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-12-29 | — | — | US | disclosed |
| EP-0021173-A1 | Maytansinoids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-01-07 | — | — | EP | disclosed |